HIGH RISK
임신 중 trifluoropropyl cyclotrisiloxane을 피해야 할까요? | VeriMom
No EU harmonised CLP (Annex VI) or Annex II/III cosmetic restriction found; supplier safety data sheets list H361 (suspected of damaging fertility or the unborn child) as a notified/self-classification, but no harmonised H360/H361 CLH entry was located on ECHA. No peer‑reviewed reproductive/developmental studies on this specific CAS (2374‑14‑3) were found in PubMed. (ECHA substance page; supplier SDS; PubChem).
ECHA regulatory hazard statements
- •H361
- •H361F
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- trifluoropropyl cyclotrisiloxane은 임신 중 안전한가요?
- No EU harmonised CLP (Annex VI) or Annex II/III cosmetic restriction found; supplier safety data sheets list H361 (suspected of damaging fertility or the unborn child) as a notified/self-classification, but no harmonised H360/H361 CLH entry was located on ECHA. No peer‑reviewed reproductive/developmental studies on this specific CAS (2374‑14‑3) were found in PubMed. (ECHA substance page; supplier SDS; PubChem).
- trifluoropropyl cyclotrisiloxane은 모유 수유 중 안전한가요?
- Same weight of evidence as pregnancy: no harmonised CMR classification or authoritative cosmetic-safety opinion (SCCS/CIR) found; some suppliers/SDSs notify reproductive hazard H361 but this appears to be company/self‑classification rather than a harmonised EU CLH. No specific data on transfer to breastmilk for this substance in the literature. (ECHA; supplier SDS).
- trifluoropropyl cyclotrisiloxane은 아기 피부에 안전한가요?
- Hazard evidence mirrors adult (no harmonised CLH; supplier self‑notifications of H361 only). Dermal exposure potential is low-to-measurable for cyclic siloxanes used topically, so exposure for infants is increased because of immature barrier and higher surface‑area‑to‑weight; per your scoring rules adult exposure scored as low (1) and infant exposure increased by +1. No infant-specific toxicokinetic or dermal absorption studies for CAS 2374‑14‑3 were found. (PubChem; supplier SDS; ECHA dossier).
- VeriMom은 trifluoropropyl cyclotrisiloxane을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 trifluoropropyl cyclotrisiloxane을 33/100 (높은 위험)로 평가합니다.
- 임신 중 trifluoropropyl cyclotrisiloxane 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.